The cost of being excluded: impact of excluded medications under Medicare part D on nursing home residents.
Stefanacci
Richard G
RG
Health Policy Institute, University of the Sciences in Philadelphia, Philadelphia, PA 19104, USA. R.Stefan@usip.edu
D000368:Aged; D000369:Aged, 80 and over; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data*; D004363:Drug Utilization / Q000191:economics; D004608:Eligibility Determination / Q000331:legislation & jurisprudence*; D005260:Female; D018166:Health Care Reform; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics / Q000331:legislation & jurisprudence*; D008297:Male; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D009735:Nursing Homes / Q000191:economics*; D009936:Organizational Innovation; D011050:Policy Making; D011786:Quality Control; D012307:Risk Factors; D014481:United States